Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Out-of-hospital mortality before 30 days was 1.2%, with roughly two-thirds of these patients dying from cardiovascular causes.

Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

In rheumatic heart disease, an autoimmune attack on the mitral valve produces thickening of the valve leaflets. The mitral valve is often described as having a "fish-mouth" appearance. Whether the ...

Inspection of the jugular venous pulsations may reveal a prominent A wave due to vigorous atrial contraction of a prominent V wave due to tricuspid regurgitation that develops from pulmonary ...

4C Medical Technologies Inc. raised $175 million in a series D financing round led by Boston Scientific Corp. The financing will support the regulatory trials and commercialization of the Altavalve ...